| 301 | NAIINatural Alternatives International Inc |
142,5 mln USD |
-14,5% |
2026 |
| 302 | BEAMBeam Therapeutics Inc. |
139,7 mln USD |
-57,2% |
2025 |
| 303 | NRCNrc Health |
137,4 mln USD |
8,2% |
2025 |
| 304 | RXSTRxSight, Inc. |
134,5 mln USD |
-29,0% |
2025 |
| 305 | AAPGAscentage Pharma Group International |
134,3 mln USD |
-41,3% |
2024 |
| 306 | XTNTXtant Medical Holdings, Inc. |
133,9 mln USD |
3,7% |
2025 |
| 307 | NAGENiagen Bioscience, Inc. |
129,4 mln USD |
13,4% |
2025 |
| 308 | LFCRLifecore Biomedical, Inc. DE |
128,9 mln USD |
-30,0% |
2025 |
| 309 | XNCRXencor Inc |
125,6 mln USD |
-73,2% |
2025 |
| 310 | GLUEMonte Rosa Therapeutics, Inc. |
123,7 mln USD |
-31,2% |
2025 |
| 311 | ATRAAtara Biotherapeutics, Inc. |
120,8 mln USD |
27,1% |
2025 |
| 312 | OMOutset Medical, Inc. |
119,5 mln USD |
-68,3% |
2025 |
| 313 | GYREGyre Therapeutics, Inc. |
116,6 mln USD |
8,5% |
2025 |
| 314 | OSUROrasure Technologies Inc |
115 mln USD |
-59,8% |
2025 |
| 315 | AGENAgenus Inc |
114,2 mln USD |
-0,1% |
2025 |
| 316 | IBRXImmunityBio, Inc. |
113,3 mln USD |
-310,2% |
2025 |
| 317 | ANIKAnika Therapeutics, Inc. |
112,8 mln USD |
-9,6% |
2025 |
| 318 | URGNUroGen Pharma Ltd. |
109,8 mln USD |
-139,8% |
2025 |
| 319 | IPSCCentury Therapeutics, Inc. |
109,2 mln USD |
-8,8% |
2025 |
| 320 | MTEXMannatech Inc |
108 mln USD |
-14,1% |
2025 |
| 321 | MDXHMDxHealth SA |
107,9 mln USD |
-31,1% |
2025 |
| 322 | TBPHTheravance Biopharma, Inc. |
107,5 mln USD |
98,5% |
2025 |
| 323 | ZVRAZevra Therapeutics, Inc. |
106,5 mln USD |
78,2% |
2025 |
| 324 | ZYMEZymeworks Inc. |
106 mln USD |
-76,6% |
2025 |
| 325 | SMTISanara MedTech Inc. |
103,1 mln USD |
-36,4% |
2025 |
| 326 | STROSutro Biopharma, Inc. |
102,5 mln USD |
-186,5% |
2025 |
| 327 | BBNXBeta Bionics, Inc. |
100,3 mln USD |
-73,0% |
2025 |
| 328 | NPCENeuroPace Inc |
100 mln USD |
-21,5% |
2025 |
| 329 | BFLYButterfly Network, Inc. |
97,6 mln USD |
-79,0% |
2025 |
| 330 | BLFSBiolife Solutions Inc |
96,2 mln USD |
-4,8% |
2025 |
| 331 | ISPRIspire Technology Inc. |
96 mln USD |
-34,6% |
2026 |
| 332 | KMTSKestra Medical Technologies, Ltd. |
95,1 mln USD |
-138,4% |
2026 |
| 333 | SIGASiga Technologies Inc |
94,6 mln USD |
24,6% |
2025 |
| 334 | LUNGPulmonx Corp |
90,5 mln USD |
-59,7% |
2025 |
| 335 | VASOVASO Corp |
89,1 mln USD |
1,8% |
2025 |
| 336 | CBLLCeribell, Inc. |
89,1 mln USD |
-60,0% |
2025 |
| 337 | BDSXBiodesix Inc |
88,5 mln USD |
-39,8% |
2025 |
| 338 | CYTKCytokinetics Inc |
88 mln USD |
-891,6% |
2025 |
| 339 | DCTHDelcath Systems, Inc. |
85,2 mln USD |
3,2% |
2025 |
| 340 | FDMT4D Molecular Therapeutics, Inc. |
85,2 mln USD |
-164,4% |
2025 |
| 341 | SPRYARS Pharmaceuticals, Inc. |
84,3 mln USD |
-203,3% |
2025 |
| 342 | NRIXNurix Therapeutics, Inc. |
84 mln USD |
-314,9% |
2025 |
| 343 | IRMDIradimed Corp |
83,8 mln USD |
26,8% |
2025 |
| 344 | ARCTArcturus Therapeutics Holdings Inc. |
82 mln USD |
-80,2% |
2025 |
| 345 | FTLFFitlife Brands, Inc. |
81,5 mln USD |
7,8% |
2025 |
| 346 | MGTXMeiraGTx Holdings plc |
81,4 mln USD |
-140,3% |
2025 |
| 347 | ADCTADC Therapeutics SA |
81,4 mln USD |
-175,3% |
2025 |
| 348 | TELATELA Bio, Inc. |
80,3 mln USD |
-48,4% |
2025 |
| 349 | ETONEton Pharmaceuticals, Inc. |
80 mln USD |
-5,8% |
2025 |
| 350 | PDEXPro Dex Inc |
77,5 mln USD |
17,6% |
2026 |